Cancer is the second leading cause of death worldwide and patients are in urgent need of therapies that can effectively target cancer with...
Read More »Mesenchymal stem cell exosomes – a two-edged sword in cancer therapy
Mesenchymal stem cells (MSCs) are multipotent stromal cells present in various adult tissues. Several studies suggest that MSCs secrete exosomes that...
Read More »Cancer-derived exosomes as a delivery platform of CRISPR/Cas9
An intracellular delivery system for CRISPR/Cas9 is crucial for its application as a therapeutic genome editing technology in a broad range of diseases. Current vehicles carrying CRISPR/Cas9 limit in vivo delivery because of low tolerance and immunogenicity; thus, the in ...
Read More »Targeting Cancer Stem Cells with Exosome-Based Therapy
Drug resistance, difficulty in specific targeting and self-renewal properties of cancer stem cells (CSCs) all contribute to cancer treatment failure and relapse. CSCs have been suggested as both the seeds of the primary cancer, and the roots of chemo- and ...
Read More »Targeting Malicious Exosomes with Gold Nanoparticles for Cancer Therapy
Exosomes are nanovesicles formed in the endosomal pathway with an important role in paracrine and autocrine cell communication. Exosomes secreted by cancer cells, malicious exosomes, have important roles in tumor microenvironment maturation and cancer progression. The knowledge of the role ...
Read More »Comparison of Two Endogenous Delivery Agents in Cancer Therapy – Exosomes and Ferritin
Schematic of the size and composition of an exosome and (apo)ferritin. Exosomes and ferritin: Two biomacromolecules from our human bodies both draw increasing interest for advanced drug delivery due to their endogenous origin and their morphology, the cage-like structures. They ...
Read More »Commonly used drugs function through extracellular vesicles
Extracellular vesicles (EVs) are attractive candidates for biomarker research, because their content reflects the parental cell status. Researchers from the University Medical Center Utrecht examined whether tumor cell derived EVs mirrored the cellular changes caused by treatment with cetuximab, a ...
Read More »Cell-derived exosomes make cell-based therapy more clinically controllable
Chimeric antigen receptor (CAR)-based T-cell adoptive immunotherapy is a distinctively promising therapy for cancer. The engineering of CARs into T cells provides T cells with tumor-targeting capabilities and intensifies their cytotoxic activity through stimulated cell expansion and enhanced cytokine production. ...
Read More »Exosomes in cancer: small particle, big player
Exosomes have emerged as a novel mode of intercellular communication. Exosomes can shuttle bioactive molecules including proteins, DNA, mRNA, as well as non-coding RNAs from one cell to another, leading to the exchange of genetic information and reprogramming of the ...
Read More »Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy
The blood-brain barrier (BBB) essentially restricts therapeutic drugs from entering into the brain. This study tests the hypothesis that brain endothelial cell derived exosomes can deliver anticancer drug across the BBB for the treatment of brain cancer in a zebrafish ...
Read More »